Happy New Year!I believe this will be a very good year for Pharmala. I had a few texts conversations with Nick. Strategically the high-net-worth investor can potentially bring many assets to the table for the company like additional cash flow if needed, knowledge and connections within the pharmaceutical industry and possibly other high-net-worth investors. I believe the potential for news out of Europe is a high possibility in the new year, but of course Nick cannot comment on any specifics one way or the other and South America is considered a viable market for the company to expand into. This does not mean they will, but Nick does see it as a potential market for the company. Nick is quite tight-lipped on information, as he should be, and that gives me confidence in his integrity as the CEO to run this company honestly and with high expectations and standards.